Incanthera plc (LSE:INC) has completed a £355,000 unsecured convertible Loan note financing, published on the same day as final results that show £4,000 of cash at 31 March 2026 and a material uncertainty over going concern. The skincare company is moving from direct-to-consumer sales to a partnership-led Supply model.
What was announced
Incanthera plc (LSE:INC) made two announcements on 29 September 2026. The first was its final results for the year to 31 March 2026. The second confirmed completion of a £355,000 financing through convertible loan notes (CLNs).
The CLN terms are:
- Unsecured notes, ranking equally as direct obligations of the company
- Interest of 3.75% a year, accruing daily and compounded annually
- Two-year maturity
- Principal and accrued interest convertible at 2p per ordinary share, once shareholders grant the required authorities
- 710,000 warrants exercisable at 2p, to be issued once Shareholder authorities are obtained, raising £14,200 if exercised in full
The company says the 2p conversion price is about an 18% discount to the ten-trading-day volume-weighted average price of 2.44p as at 28 September 2026. The notes were taken up by a mix of new and existing investors, who are not named. The proceeds will fund general working capital, commercial discussions with iSmart Developments Limited (first announced on 7 September 2026) and payments to creditors. The results announcement states that £105,000 of the £355,000 had been received by the date the accounts were signed.
The numbers
For the year to 31 March 2026, Incanthera reported:
- Revenue of £12,000, its first commercial Revenue (2025: nil)
- A gross loss of £356,000, after direct costs of £368,000
- An operating loss of £2.276m (2025: £1.997m)
- A loss before tax of £2.168m (2025: £1.997m)
- A loss per share of 1.62p (2025: 1.77p)
Cash at the year end was £4,000, compared with £80,000 a year earlier. Trade payables rose to £1.508m from £547,000. The company had net liabilities of £475,000, compared with net Assets of £1.153m a year earlier.
The revenue came from the skin+CELL direct-to-consumer launch in August 2025. The company says sales "fell short of expectations", even after an institutional fundraising of £508,000 in June 2025.
The directors report a material uncertainty over going concern. Their assessment assumes a "significant increase in revenues". It also relies on a separate convertible loan Facility of up to £250,000 made available by chief executive Stuart Robertson, of which £100,000 had been drawn at the date of the statement. Directors have also agreed to take share Options instead of cash payments.
Strategy and background
After the year end, the company made several changes. It bought the Swiss premium skincare Brand énielle, on terms that have not been disclosed. It signed an exclusive bundled distribution agreement with iSmart Developments for LED skincare devices. It also rebuilt its board. Stuart Robertson became chief executive in June 2026, alongside Caroline Murray as chair, Simon Ward as chief scientific officer, Laura Brogden as chief financial officer and Werner Bürki as a non-executive director.
Robertson said the company is "transitioning from a marketing-led, direct-to-consumer Business to a more focused contracted, partnership-led supplier". The plan is to focus on suncare and protection products, partnerships for LED devices, and international distribution through established partners rather than building its own infrastructure.
What to watch next
The CLNs can only convert, and the warrants can only be issued, once shareholders grant the necessary authorities. Details of the 2026 Annual General Meeting will be announced separately. Other points to watch are:
- progress in the iSmart Developments discussions
- revenue from the énielle brand and the new Partnership model
- any further drawdowns on the chief executive's facility
The announcements do not say how long current funding is expected to last. They also do not quantify the increase in revenue the directors have assumed.






Please wait processing your request...